Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05106_nanopub.RAKx5yYlQUtxYf44zdnUfomvddNliYiLrHFrqijwHdnZ4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05106 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05106 label "IR208 [drugbank:DB05106]" assertion.
- drugbank:DB05106 seeAlso DB05106 assertion.
- drugbank:DB05106 description "IR208 is a synthetic T-Cell receptor peptide vaccine developed by Immune Response Corporation. It contains three peptides (BV5S2, BV6S5 and BV13S1) expressed by T-Cells in over 90% of MS patients. IR208 is currently undergoing Phase II studies in a 200-patient trial." assertion.
- drugbank:DB05106 identifier "drugbank:DB05106" assertion.
- drugbank:DB05106 title "IR208" assertion.
- drugbank:DB05106 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05106 drugbank_vocabulary:drugbank-id "DB05106" assertion.
- drugbank:DB05106 bio2rdf_vocabulary:x-identifiers.org DB05106 assertion.
- drugbank:DB05106 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05106" assertion.
- drugbank:DB05106 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05106 bio2rdf_vocabulary:identifier "DB05106" assertion.